SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-066451
Filing Date
2021-11-23
Accepted
2021-11-23 16:36:05
Documents
2
Period of Report
2021-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1639
2 POA DOCUMENT poa.txt EX-24 3571
  Complete submission text file 0001209191-21-066451.txt   6745
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IN8BIO, INC. 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address
Goswami Trishna (Reporting) CIK: 0001894243 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 211439006